PUBLISHER: Grand View Research | PRODUCT CODE: 1493291
PUBLISHER: Grand View Research | PRODUCT CODE: 1493291
The global aesthetic injectable market size is expected to reach USD 24.13 billion by 2030, registering a CAGR of 12.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The industry is experiencing notable growth driven by several factors. These include increasing consumer awareness about minimally invasive cosmetic procedures, advancements in injectable technologies, and rising demand for non-surgical aesthetic enhancements.
Technological and research progress has led to the development of inventive injectable formulations, expanding the market's offerings to include various products addressing precise concerns like fine lines, wrinkles, volume loss, and skin texture. For instance, according to the National Center for Biotechnology and Information (NCBI) in January 2024, the injectable Sculptra Poly-L-Lactic Acid (PLLA-SCA) treatments were well received and notably diminished the severity of moderate to severe wrinkles and cheek lines while enhancing skin quality. Their effectiveness remained consistent throughout the 12-month study, with subjects reporting high satisfaction, achieving a natural appearance, and expressing eagerness for further treatments.
Additionally, shifting beauty standards and a growing aging population contribute to market expansion. Moreover, the availability of a wide range of injectable products, coupled with innovative marketing strategies by key players, further stimulates market growth. Furthermore, favorable regulatory frameworks and an expanding network of aesthetic clinics and medical spas are fostering the uptake of aesthetic injectables worldwide.